Influence of hepatitis B virus virema upon serum aminotransferase activity in dialysis population

International Journal of Artificial Organs

Volumn 26, Issue 12, 2003, Pages 1048-1055

  Fabrizi, Fabrizio ^a   Mangano, S ^d   Alongi, G ^b   Bisegna, S ^c   Finazzi, S ^a   Lunghi, G ^a   Ponticelli, C ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b Nephrology Units   (Italy)

^c Nephrology Units ^*

^d Sant'Anna Como Hospital   (Italy)

Author keywords

Aminotransferase; Dialysis; HBV viral load; Hepatitis B virus

Indexed keywords

BODY FLUIDS; DIALYSIS; DISEASE CONTROL; DISEASES; MULTIVARIANT ANALYSIS; PATIENT MONITORING; PATIENT TREATMENT; POLYMERASE CHAIN REACTION; POPULATION STATISTICS;

AMINOTRANSFERASE; AMINOTRANSFERASE ACTIVITIES; END-STAGE RENAL DISEASE; HEPATITIS B VIRUS; HEPATITIS B VIRUS INFECTION; HEPATITIS B VIRUS VIRAL LOAD; HEPATOCELLULAR; LIVER DISEASE; VIRAL LOAD;

VIRUSES;

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIALYSIS; ENZYME ACTIVITY; FEMALE; HEMODIALYSIS PATIENT; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION CONTROL; INFECTION RISK; INTERMETHOD COMPARISON; ITALY; KIDNEY FAILURE; LIVER CELL DAMAGE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIREMIA; VIROLOGY; VIRUS LOAD; VIRUS TRANSMISSION;

EID: 1242319502     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880302601202     Document Type: Article

References (45)

1. Tokars JI, Miller ER, Alter MJ, Arduino MJ. National surveillance of dialysis-associated diseases in the United States. Semin Dial 2000; 13: 75-85.
2. Centers for Disease Control and Prevention. Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR 2001; 50 (RR-5): 1-43.
3. Friedman EA, Thomson GE. Hepatitis complicating chronic hemodialysis. Lancet 1966; 2: 675-8.
4. Garibaldi RA, Forrest JN, Bryan JA, Hanson BF, Dismukes WE. Hemodialysis-associated hepatitis. JAMA 1973; 225: 384-9.
5. Parsons FM, Brunner FP, Gurland HJ, Harlen H. Combined report of regular dialysis and transplantation in Europe. Proc Eur Dial Transplant Assoc 1971; 8: 3-27.
6. Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, Wolfe RA, Jones E, Disney AP, Briggs D, McCredie M, Boyle P. Cancer in patients on dialysis for end-stage renal disease: An international collaborative study. Lancet 1999; 354: 93-9.
7. Josselson J, Kyser BA, Weir MR, Sadler JH. Hepatitis B surface antigenemia in a chronic hemodialysis program: Lack of influence on morbidity and mortality. Am J Kidney Dis 1987; 6: 456-61.
8. Jha R, Kher BA, Naik S, Elhence R, Gupta A, Sharma RK. Hepatitis B associated liver disease in dialysis patients: role of vaccination. J Nephrol 1993; 6: 98-103.
9. Marcelli D, Stanhard D, Conte F, Held PJ, Locatelli F, Port FK. ESRD patients mortality with adjustment for comorbid conditions in Lombardy (Italy) versus the United States. Kidney Int 1996; 50: 1013-8.
10. Sherman KE. Alanine aminotransferase in clinical practice. Ann Intern Med 1991; 151: 2260-5.
11. Amplicor HBV Monitor™ Test Kit: Roche Diagnostics, Branchburg, NJ, USA 1999 (package insert).
12. Vladutiu D, Cosa A, Neamtu A, State D, Braila M, Gherman M, Patiu IM, Dulau-Florea I. Infection with hepatitis B and C viruses in patients on maintenance dialysis in Romania and in former communist countries: Yellow spots on a blank map? J Viral Hepat 2000; 7: 313-9.
13. Jankovic N, Cala S, Nadinic B, Varlai-Knobloch V, Pavlovic D. Hepatitis C and hepatitis B virus infection in hemodialysis patients and staff: a two year follow-up. Int J Artif Organs 1994; 17: 137-40.
14. Cendoroglo Neto N, Rodrigues Manzano SI, Canziani ME, Silva AEB, Cirenza MLF, de Cintra Sesso R, Ajzen H, Draibe SA. Environmental transmission of hepatitis B and hepatitis C viruses within the hemodialysis unit. Artif Organs 1995; 19: 251-5.
15. Covic A, Iancu L, Apetrei C, Scripcaru D, Volovat C, Mititiuc I, Covic M. Hepatitis virus infection in haemodialysis patients from Moldavia. Nephrol Dial Transplant 1999; 14: 40-5.
16. Centers for Disease Control and Prevention. Outbreaks of hepatitis B virus infection among hemodialysis patients-California, Nebraska, and Texas, 1994. JAMA 1996; 275: 1394-5.
17. Hutin YJF, Goldstein ST, Varma JK, O'Dair JB, Mast EE, Shapiro CN, Alter MJ. An outbreak of hospital-acquired hepatitis B virus infection among patients receiving chronic hemodialysis. Infect Control Hosp Epidemiol 1999; 20: 731-5.
18. Tanaka S, Yoshiba M, Lino S, et al. A common-source outbreak of fulminant hepatitis B in hemodialysis patients induced by precore mutants. Kidney Int 1995; 48: 1972-8.
19. Lewis-Ximenez LL, Oliveira JM, Mercadante LAC, De Castro L, Santa Catharina W, Stuver S, Yoshida CFT. Serological and vaccination profile of hemodialysis patients during an outbreak of hepatitis B virus infection. Nephron 2001; 87: 19-26.
20. Roll M, Norder H, Magnius O, Grillner L, Lindgren V. Nosocomial spread of hepatitis B virus (HBV) in a haemodialysis unit confirmed by HBV DNA sequencing. J Hosp Infect 1995; 30: 57-63.
21. Kohler H. Hepatitis B immunization in dialysis patients - is it worthwhile? Nephrol Dial Transplant 1994; 9: 1719-20.
22. Pao CC, Yang WL, Huang CC, Hsu JL, Lin SS, Ken R, Chao Y, Sun CF, Liaw JW, Lin JY. Hepatitis type B virus DNA in patients receiving hemodialysis: correlation with other HBV serological markers. Nephron 1987; 46: 155-60.
23. Coughlin GP, Van Deth AG, Disney APS, Hay J, Wangel AG. Liver disease and the e antigen in HBsAg carriers with chronic renal failure. Gut 1980; 21: 118-22.
24. Gahl GM, Hess G, Arnold W, Grams G. Hepatitis B virus markers in 97 long-term hemodialysis patients. Nephron 1979; 24: 58-63.
25. Degott C, Degos F, Jungers P, Naret C, Couroucè AM, Potet F, Crosnier J. Relationship between liver histopathological changes and HBsAg in 111 patients treated by long-term hemodialysis. Liver 1983; 3: 377-84.
26. Guh JY, Lai YH, Yang CY, Chen SC, Chuang WL, Hsu TC, Chen HC, Chang WY, Tsai JH. Impact of decreased serum transaminase levels on the evaluation of viral hepatitis in hemodialysis patients. Nephron 1995; 69: 459-65.
27. Hung KY, Lee KC, Yen CJ, Wu KD, Tsai TJ, Chen WY. Revised cut-off values of serum aminotransferase in detecting viral hepatitis among CAPD patients: Experience from Taiwan, an endemic area for hepatitis B. Nephrol Dial Transplant 1997; 12: 180-3.
28. Yasuda K, Okuda K, Endo N, Ishiwatari Y, Ikeda R, Hayashi H, Yokozeki K, Kobayashi S, Irie Y. Hypoaminotransferasemia in patients undergoing long-term hemodialysis: Clinical and biochemical appraisal. Gastroenterology 1995; 109: 1295-300.
29. Sheu JC, Lee SH, Wang JT, Shih LN, Wang TH, Chen DS. Prevalence of anti-HCV and HCV viremia in hemodialysis patients in Taiwan. J Med Virol 1992; 37: 108-12.
30. Chimata M, Masaoka H, Fujmaki M, Hamada N, Oda K, Sudo M, Nagase M. Low serum aminotransferase activity in patients undergoing regular hemodialysis. Nippon Jinzo Gakkai Shi 1994; 36: 389-5.
31. Crawford DR, Reyna RS, Weiner MW. Effects of in vivo and in vitro dialysis on plasma transaminase activity. Nephron 1978; 22: 418-22.
32. Cohen GA, Goffinet JA, Donabedian RK, Conn HO. Observations on decreased serum glutamic oxaloacetic transaminase (SGOT) activity in azotemic patients. Ann Intern Med 1976; 84: 275-80.
33. Wolf PL, Williams D, Coplon N, Coulson AS. Low aspartate aminotransferase activity in serum of patients undergoing chronic hemodialysis. Clin Chem 1972; 18: 567-8.
34. Warnock LG, Stone WJ, Wagner C. Decreased aspartate aminotransferase (SGOT) activity in serum of uremic patients. Clin Chem 1974; 20: 1213-6.
35. Espinosa M, Martin-Malo A, Alvarez-de Lara MA, Soriano S, Aljama P. High ALT levels predict viremia in anti-HCV-positive HD patients if a modified normal range of ALT is applied. Clin Nephrol 2000; 54: 151-6.
36. Cabrerizo M, Bartolomè J, Caramelo C, Barril G, Carreno V. Molecular analysis of hepatitis B virus DNA in serum and peripheral blood mononuclear cells from hepatitis B surface antigen-negative cases. Hepatology 2000; 32: 116-23.
37. Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337: 1733-45.
38. Fabrizi F, Lunghi G, Andrulli S, Faranna P, Pagliari B, Mangano S, Pagano A, Locatelli F. Influence of hepatitis C viremia upon serum aminotransferase activity in chronic dialysis patients. Nephrol Dial Transplant 1997; 12: 1394-8.
39. Mondelli MU, Smedile V, Piazza V, Villa G, Barbieri C, Gattarello G, Mancini F, Raimondo G. Abnormal alanine aminotransferase activity reflects exposure to hepatitis C virus in hemodialysis patients. Nephrol Dial Transplant 1991; 6: 480-3.
40. Knudsen F, Wantzin P, Rasmussen K, Ladefoged SD, Lokkegaard N, Rasmussen LS, Lassen A, Krogsgaard K. Hepatitis C in dialysis patients: Relationship to blood transfusions, dialysis and liver disease. Kidney Int 1993; 43: 1353-6.
41. Fabrizi F, Martin P, Dixit V, Brezina M, Cole MJ, Gerosa S, Vinson S, Mousa M, Gitnick G. Quantitative assessment of HCV load in chronic haemodialysis patients: A cross-sectional survey. Nephron 1998; 80: 428-33.
42. Martin P, Carter D, Fabrizi F, Dixit V, Conrad A, Artinian L, Peacock V, Han S, Wilkinson A, Lassman CR, Danovitch G. Histopathological features of hepatitis C in renal transplant candidates. Transplantation 2000; 69: 1479-84.
43. Fabrizi F, Lunghi G, Finazzi S, Colucci P, Pagano A, Ponticelli C, Locatelli F. Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis. Am J Kidney Dis 2001; 38: 1009-15.
44. Beasley RP, Hwang LY, Lin CC, Chien SS. Hepatocellular carcinoma and hepatitis B virus: A prospective study of 22707 men in Taiwan. Lancet 1981; 2: 1129-33.
45. Yang HI, Lu SN, Liaw YF, You SL, Sun CA, Wang LY, Hsiao CK, Chen PJ, Chen DS, Chen CJ, for the Taiwan Community-Based Cancer Screening Project Group. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 2002; 347: 168-74.